316 related articles for article (PubMed ID: 3876396)
1. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
[TBL] [Abstract][Full Text] [Related]
2. A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid.
Fransen L; Nsanze H; Jo-Ndinya-Achola ; D'Costa L; Ronald AR; Piot P
Sex Transm Dis; 1987; 14(2):98-101. PubMed ID: 2956702
[TBL] [Abstract][Full Text] [Related]
3. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group.
Barnett ED; Teele DW; Klein JO; Cabral HJ; Kharasch SJ
Pediatrics; 1997 Jan; 99(1):23-8. PubMed ID: 8989332
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity.
Fast MV; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Piot P; Albritton WL; Ronald AR
Sex Transm Dis; 1983; 10(1):1-6. PubMed ID: 6601847
[TBL] [Abstract][Full Text] [Related]
6. Treatment of gonorrhea with trimethoprim-sulfamethoxazole.
Elliott WC; Reynolds G; Thornsberry C; Kellogg DS; Jaffe HW; Brown ST; Armstrong J; Rein MF
J Infect Dis; 1977 Jun; 135(6):939-43. PubMed ID: 405433
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid.
Plourde PJ; D'Costa LJ; Agoki E; Ombette J; Ndinya-Achola JO; Slaney LA; Ronald AR; Plummer FA
J Infect Dis; 1992 May; 165(5):949-52. PubMed ID: 1569347
[TBL] [Abstract][Full Text] [Related]
8. The treatment of chancroid.
Schmid GP
JAMA; 1986 Apr; 255(13):1757-62. PubMed ID: 3512872
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Ismaeel NA
Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole.
Fast MV; Nsanze H; Plummer FA; D'Costa LJ; MacLean IW; Ronald AR
Br J Vener Dis; 1983 Oct; 59(5):320-4. PubMed ID: 6351957
[TBL] [Abstract][Full Text] [Related]
12. Single-dose therapy of chancroid with trimethoprim-sulfametrole.
Plummer FA; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Ellison RH; Ronald AR
N Engl J Med; 1983 Jul; 309(2):67-71. PubMed ID: 6343878
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen.
Dylewski J; Nsanze H; D'Costa L; Slaney L; Ronald A
J Antimicrob Chemother; 1985 Jul; 16(1):103-9. PubMed ID: 3876325
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.
Naamara W; Plummer FA; Greenblatt RM; D'Costa LJ; Ndinya-Achola JO; Ronald AR
Am J Med; 1987 Apr; 82(4A):317-20. PubMed ID: 3555055
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii.
Young LS
Rev Infect Dis; 1982; 4(2):608-13. PubMed ID: 6981177
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
Nissenson AR; Wilson C; Holazo A
Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
[TBL] [Abstract][Full Text] [Related]
19. Comparison of azithromycin and ceftriaxone for the treatment of chancroid.
Martin DH; Sargent SJ; Wendel GD; McCormack WM; Spier NA; Johnson RB
Clin Infect Dis; 1995 Aug; 21(2):409-14. PubMed ID: 8562752
[TBL] [Abstract][Full Text] [Related]
20. Intravenous single-dose ceftriaxone treatment of chancroid.
Hartmann AA; Elsner P; Burg G
Dermatologica; 1991; 183(2):132-5. PubMed ID: 1743374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
